Jump to content

ASCO Update: Molecular Selection of Chemo for Advanced NSCLC


Recommended Posts

ASCO Update: Molecular Selection of Chemo for Advanced NSCLC Fails to Deliver

June 10th, 2013 - by Dr. Jack West

http://expertblog.lungevity.org/2013/06 ... o-deliver/

Dr. Mary Pinder, from Moffitt Cancer Center in Tampa, FL, was one of the investigators very involved in a high profile trial called MADeIT, which directly tested whether we might do better with chemo by selecting a particular regimen for each patient based on molecular markers for the cancer. Here’s her discussion of the trial, along with another from Spain presented at ASCO 2013 that demonstrated no improvement in outcomes with this approach, and the implications of this work for treatment of advanced NSCLC today: (Click link above to view the video)

Molecular Selection of Chemo for NSCLC ASCO 2013 Trials Video

More to come, including some video summaries that describe more encouraging results!

-Dr. West

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...